Combination drug strategy produces promising results by hyperactivating oncogenic signaling

Combination drug strategy produces promising results by hyperactivating oncogenic signaling

FGF2 impairs cell cycle progression in K-Ras-driven cancer cells. Serum-starved Y1D1 cells were stimulated by 10% serum with or without 10 ng·mL−1 FGF2 to re-entry the cell cycle. Cells were subjected to a BrdU pulse 30…

[ad_2]

Source link

More From Author

What to know about ‘Teflon flu’ amid a rise in cases in the US

What to know about ‘Teflon flu’ amid a rise in cases in the US

Here are the streets that will be closed during the SF Marathon – SFGATE

Leave a Reply

Your email address will not be published. Required fields are marked *